A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Clinical trial NCT05608044 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05608044
- Sponsor
- Agenus Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2027-09-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.